Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (291-300 of 353) with videos related to

Pageof 36
Sort By:
JAMA Network Open|December 27, 2023
Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical TrialShalender Bhasin, Thomas G Travison, Karol M Pencina, et al.
Journal of the American Heart Association|June 23, 2026
Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic AcidG B John Mancini, A Michael Lincoff, Anne C Goldberg, et al.
American Heart Journal|December 19, 2015
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trialStephen J Nicholls, A Michael Lincoff, Philip J Barter, et al.
Obesity (Silver Spring, Md.)|February 14, 2025
Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trialRobert F Kushner, Donna H Ryan, John Deanfield, et al.
Circulation|November 25, 2016
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)C Michael Gibson, Serge Korjian, Pierluigi Tricoci, et al.
JAMA|December 7, 2007
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trialGregg W Stone, James H Ware, Michel E Bertrand, et al.
The New England Journal of Medicine|November 12, 2023
Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesA Michael Lincoff, Kirstine Brown-Frandsen, Helen M Colhoun, et al.
Circulation|March 30, 2011
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesR Scott Wright, Jeffrey L Anderson, Cynthia D Adams, et al.
Circulation|July 18, 2012
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, Hani Jneid, Jeffrey L Anderson, et al.
JACC. Advances|July 30, 2024
Interleukin-6 and Cardiovascular Events in Healthy Adults: MESAMuhammad Shahzeb Khan, Khawaja M Talha, Muhammad Haisum Maqsood, et al.
Pageof 36

Showing results (291-300 of 353) with videos related to

Sort By:
Pageof 36
JAMA Network Open|December 27, 2023
Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical TrialShalender Bhasin, Thomas G Travison, Karol M Pencina, et al.
Journal of the American Heart Association|June 23, 2026
Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic AcidG B John Mancini, A Michael Lincoff, Anne C Goldberg, et al.
American Heart Journal|December 19, 2015
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trialStephen J Nicholls, A Michael Lincoff, Philip J Barter, et al.
Obesity (Silver Spring, Md.)|February 14, 2025
Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trialRobert F Kushner, Donna H Ryan, John Deanfield, et al.
Circulation|November 25, 2016
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)C Michael Gibson, Serge Korjian, Pierluigi Tricoci, et al.
JAMA|December 7, 2007
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trialGregg W Stone, James H Ware, Michel E Bertrand, et al.
The New England Journal of Medicine|November 12, 2023
Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesA Michael Lincoff, Kirstine Brown-Frandsen, Helen M Colhoun, et al.
Circulation|March 30, 2011
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesR Scott Wright, Jeffrey L Anderson, Cynthia D Adams, et al.
Circulation|July 18, 2012
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, Hani Jneid, Jeffrey L Anderson, et al.
JACC. Advances|July 30, 2024
Interleukin-6 and Cardiovascular Events in Healthy Adults: MESAMuhammad Shahzeb Khan, Khawaja M Talha, Muhammad Haisum Maqsood, et al.
Pageof 36